Drug Type Cytokines |
Synonyms |
Target |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists), NKp46 agonists(Natural cytotoxicity triggering receptor 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 25 Mar 2022 |